New research confirms that increased screen time did lead to more eye strain in children, as well as a more troubling eye condition called convergence insufficiency, which can cause difficulty reading.
With in-person school just around the corner and a September target date for many to return to the office, a Northwestern Medicine eye expert is urging awareness of eye health. Michelle E. Andreoli, MD, an ophthalmologist at Northwestern Medicine Regional Medical Group…
The July/August 2021 issue of the Journal of VitreoRetinal Diseases (JVRD), the official peer-reviewed, scientific journal of the American Society of Retina Specialists, has been published.
A University of Utah Health ophthalmologist is investigating how lipids known as VLC-PUFAs could be used to prevent eye disease thanks to a new way to synthesize them for research.
The Association for Research in Vision and Ophthalmology (ARVO) today announced Yohei Tomita, MD, PhD, has received the 2021 Bert M. Glaser, MD Award for Innovative Research in Retina, which recognizes an early-career investigator who has made a novel discovery that impacted the understanding and/or treatment of a retinal disease or condition. Tomita is recognized with this award for his retinal translational research, with a focus on diabetic retinopathy (DR) and age-related macular degeneration (AMD).
In older people with type 1 diabetes, damage to the retina may be linked to memory problems and other cognitive conditions.BOSTON – (December 31, 2020) – As they age, people with diabetes are more likely to develop Alzheimer’s disease and other cognitive disorders than are people without diabetes. Scientists at Joslin Diabetes Center now have shown that routine eye imaging can identify changes in the retina that may be associated with cognitive disorders in older people with type 1 diabetes.
Wills Eye Hospital has earned a top national ranking for the 31st consecutive year on U.S. News & World Report’s Annual Best Hospital’s Survey.
The Association for Research in Vision and Ophthalmology (ARVO) and ARVO Foundation for Eye Research announce the opening of nominations for their respective awards, including three new awards— the Genentech Career Development Award for Underrepresented Minority Emerging Vision Scientists, the Achievements in Eye and Vision Advocacy Award, and the Emerging Advocate Award—on July 1, 2020.
AveXis, will lead the manufacturing efforts of the new AAVCOVID vaccine, utilizing its cutting-edge AAV technology for treatment of rare and life-threatening neurological genetic diseases. AveXis has the option to manufacture the AAV vaccine for additional clinical development, registration and/or commercial activities.
Wills Eye Hospital is pleased to announce John J. Zabinski has been named Chief Development Officer.